These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 10179649)

  • 1. Profit pools: a fresh look at strategy.
    Gadiesh O; Gilbert JL
    Harv Bus Rev; 1998; 76(3):139-47. PubMed ID: 10179649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to map your industry's profit pool.
    Gadiesh O; Gilbert JL
    Harv Bus Rev; 1998; 76(3):149-52, 154, 156 passim. PubMed ID: 10179650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value innovation: the strategic logic of high growth.
    Kim WC; Mauborgne R
    Harv Bus Rev; 1997; 75(1):102-12. PubMed ID: 10174449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M&A needn't be a loser's game.
    Selden L; Colvin G
    Harv Bus Rev; 2003 Jun; 81(6):70-9, 137. PubMed ID: 12800718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Take command of your growth.
    Treacy M; Sims J
    Harv Bus Rev; 2004 Apr; 82(4):127-33, 142. PubMed ID: 15077373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The five competitive forces that shape strategy.
    Porter ME
    Harv Bus Rev; 2008 Jan; 86(1):78-93, 137. PubMed ID: 18271320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastering the value chain. An interview with Mark Levin of Millennium Pharmaceuticals. Interview by David Champion.
    Levin M
    Harv Bus Rev; 2001 Jun; 79(6):108-15, 148. PubMed ID: 11408971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making business sense of the Internet.
    Ghosh S
    Harv Bus Rev; 1998; 76(2):126-35. PubMed ID: 10177862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative value of growth.
    Mass NJ
    Harv Bus Rev; 2005 Apr; 83(4):102-12, 134. PubMed ID: 15807043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How much cash does your company need?
    Passov R
    Harv Bus Rev; 2003 Nov; 81(11):119-22, 124-6, 128, 140. PubMed ID: 14619157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Countering the biggest risk of all.
    Slywotzky AJ; Drzik J
    Harv Bus Rev; 2005 Apr; 83(4):78-88, 133. PubMed ID: 15807041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing on capabilities: the new rules of corporate strategy.
    Stalk G; Evans P; Shulman LE
    Harv Bus Rev; 1992; 70(2):57-69. PubMed ID: 10117369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's wrong with strategy?
    Campbell A; Alexander M
    Harv Bus Rev; 1997; 75(6):42-51. PubMed ID: 10174797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CFOs and strategists: forging a common framework.
    Rappaport A
    Harv Bus Rev; 1992; 70(3):84-91. PubMed ID: 10118005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profitability of Large Pharmaceutical Companies Compared With Other Large Public Companies.
    Ledley FD; McCoy SS; Vaughan G; Cleary EG
    JAMA; 2020 Mar; 323(9):834-843. PubMed ID: 32125401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategy as revolution.
    Hamel G
    Harv Bus Rev; 1996; 74(4):69-82. PubMed ID: 10158475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How industries change.
    McGahan AM
    Harv Bus Rev; 2004 Oct; 82(10):86-94, 156. PubMed ID: 15559578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovating for cash.
    Andrew JP; Sirkin HL
    Harv Bus Rev; 2003 Sep; 81(9):76-83, 132. PubMed ID: 12964395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Companies and the customers who hate them.
    McGovern G; Moon Y
    Harv Bus Rev; 2007 Jun; 85(6):78-84, 141. PubMed ID: 17580650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making real options really work.
    van Putten AB; MacMillan IC
    Harv Bus Rev; 2004 Dec; 82(12):134-41, 150. PubMed ID: 15605572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.